Biometric Company NXT-ID, Inc. Announces Limited Edition Wocket™ to Shareholders of Record May 23, 2014

SHELTON, Conn., May 1, 2014 /PRNewswire/ -- NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused on the growing m-commerce market, reports it is offering a limited edition  "Signature" Wocket smart wallet to its shareholders.  Wocket™ is a next generation smart wallet, designed to replace all the cards in your wallet.

The company also announces that the retail pricing for Wocket will be $149.99.

Mr, Gino Pereira, CEO of NXT-ID, Inc. said , "Shareholders of record owning 100 shares or more as of May 23rd, 2014 that advance order, and pay for, a Wocket on the website www.wocketwallet.com between May 28th and June 15th, 2014 will be issued a special limited "Signature" edition Wocket."

NXT-ID is currently launching a marketing campaign for its smart wallet, Wocket™, which is designed to protect your identity and replace all the cards in your wallet, no smart phone required. A series of CNBC ads will start airing during prime-time hours commencing the week of May 12th, followed by a press conference and marketing event for media and shareholders May28th at the Plaza Hotel in New York. Advance ordering will be available online following the event. Additional marketing will include online and print ads for Wocket's launch.  

"Some of the largest, most successful companies have implemented similar opportunities to share the benefits of their companies with their shareholders. This is a way for us to thank our shareholders that believe in our next generation technology," said Gino Pereira, CEO of NXT-ID, Inc. "We believe can change the whole wallet industry. The wallet is the last bastion of the pre-digital age. We intend to change that by providing a modern smart wallet that is both comfortable and convenient to use, all the while protecting your identity and assets; it's your personal vault."

Wocket™ is a smart wallet in the same vein as the smart phone and smart watch. NXT-ID is introducing its innovative, patent-pending Wocket™ as the next natural step in the evolution of smart devices. Wocket™ is a next generation smart wallet designed to protect your identity and replace all the cards in your wallet, with no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.

Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records, coupons, etc. and 100 voice commands can also be stored on Wocket™.

Media and shareholders wishing to attend the May 28th  Plaza Hotel event ( from 3:00 to 5:00 P.M.) can email info@nxt-id.com and request to be added to the limited guest list.

Interested consumers can also sign up for product info and news alerts in anticipation of the product.  Advance ordering will be available following the May 28th event at http://www.wocketwallet.com/

The Wocket product FAQ is available to consumers and media at http://nxt-id.com/wocket-faq/

About NXT- ID Inc. - Mobile Security for a Mobile World

NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™ ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.wocketwallet.com/

NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, the Company's securities.

Forward-Looking Statements for NXT-ID

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

Contact:

Corporate info: info@nxt-id.com

Investor Inquiries:

Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
ksmith@proactivecapital.com

Media: 800 665-0411

SOURCE NXT-ID, Inc.

RELATED LINKS
http://www.nxt-id.com

reade more... Résuméabuiyad

MedBox responds to critics and update on the status of issues to the shareholders of the company

WEST HOLLYWOOD, California, 18 February of 2014/PRNewswire /-Medbox, Inc. (OTC markets: MDBX) (www.medboxinc.com), a leader in consulting services services and systems patented medical industries and retail, issued a report to its shareholders in projects past, present and future. Company executives also comment on the bloggers seek to discredit the company to make money and law firms seeking to capitalize on misinformation in order to request from customers.

The following is a summary of the main events in the last few weeks:

MedBox filed its form 10 with the SEC in January and will be an SEC filer, with all the burdens and benefits resulting from that condition, from the middle of March 2014. MedBox issued a special stock dividend to shareholders and which was announced by FINRA on February 03, 2014. MedBox continues to accept customers licensing clinic in Nevada, Illinois, Colorado, Washington and Oregon. Executives of the company clarified its position on the restatement of financial statements that accompanied the registration statement form 10 filed with the SEC as a maturation process in becoming a Cabinet sec.

"The company undertook a project to bring the functions of accounting at home and during that long process we discovered some errors in accounting since then we have corrected the last financial statements included in the form 10. The point is to hit and be fully transparent with our stakeholders at all times,"said Vincent Mehdizadeh, Chairman at Medbox, Inc."the company has, as part of these corrections, instituted better controls over financial reporting to avoid major corrections. In addition, it is important to point out that revenues in the nine months of the year 2013 had increased during the comparative period of the year before (as corrected) and continue to add qualified people to accelerate our growth in the year 2014. Unfortunately, when you are the most visible company in the space, with a large market capitalization, you become a target."

Executives of the company caution the shareholders of the company while the media has been of great help Medbox as one of the only viable medical marijuana related to public companies, successfully there will always be opponents who publish deceptive and misleading articles about the company and its executives.

In addition, company executives said that the company offers support services to the sector of medical marijuana based on the length of an arm. Many times in a State where you are accepting applications for marijuana dispensary licenses, some owners are not leased to nonprofit entities recently formed made up of clients of the company. As a result, in some rare cases, and simply as an absolute benefit to its customers, it was agreed that Medbox lease properties and assign all rights to the applicant, with the permission of the owner.

"We are going the extra mile for our customers and that is evident through our glowing testimonials appear on our web sites," said Dr. Bruce Bedrick, CEO at Medbox, Inc. "it is interesting, with the recent banking policy guidance from the federal Government, now can begin to develop an additional source of income to acquire properties and lease clients of clinic operator." This is one of many sources of revenue that Medbox is developing actively given the current climate and the relaxed posture federal".

About Medbox, Inc.:

MedBox is a leader in the development, sales and service of systems of automated dosing and storage, biometrically controlled medicine and merchandise. MedBox has offices in New York, Arizona, Florida, and is headquartered in Los Angeles.

MedBox offers its patented systems, software and consulting services to pharmacies, clinics, urgent care centers, clinics of rehabilitation from drugs, hospitals, prison systems, hospice services and medical groups around the world. In addition, through its subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers a medical product industry award-winning vaporizer.

MedBox, Inc. is a company that is listed and traded in the OTC symbol MDBX markets.

Forward-looking statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. These statements are based on current beliefs and expectations and are inherently subject to important business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future strategies and decisions that are subject to change. We do not assume any obligation to update any forward-looking statements to reflect events or developments then made a statement with a vision for the future.

For more information about Medbox, please contact us at (800) 762-1452 or visit www.medboxinc.com.

Contacts:
Investor relations
Stephen Hart
Hayden IR
+ 1 - 917-658-7878
Hart@HaydenIR.com

SOURCE Medbox, Inc.

RELATED LINKS
http://www.medboxinc.com

reade more... Résuméabuiyad

Medbox Issues Special Stock Dividend to Shareholders

WEST HOLLYWOOD, Calif., Feb. 3, 2014 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry specific consulting services and patented systems to the medical and retail industries, announced FINRA consent and issuance of a common stock dividend.  The 100% stock dividend issuance will have a record date of December 18th, 2013, and a pay date of February 3rd, 2014.

Management clarified that the class of shares to receive the dividend is the common shares only and not the preferred class of shares held by company executives. The shares are issued on a one-year restricted basis.

"I am extremely elated that we were able to give back to our shareholders in this way," stated Vincent Mehdizadeh, COO at Medbox, Inc. "Being a leader means setting a good example for other companies in the medical marijuana industry to follow. As we transition to becoming an SEC filer in mid-March, its important that we now focus on strengthening our management team, which is our next key priority."

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Florida, and has their corporate headquarters in West Hollywood, California.

Medbox offers their patented systems, software and consulting services to pharmacies, dispensaries and medical groups worldwide. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical vaporizer product.

Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets (Pink Sheets), ticker symbol MDBX.

Forward-Looking Statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws.  Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control.  In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change.  Potential risks and uncertainties include, but are not limited to, technical advances in the industry, political conditions and economic conditions in the states considering such legislation.  We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

For more information on Medbox, please contact us at (800) 762-1452 or go online to www.medboxinc.com.

Contacts:
Investors                                  
Stephen Hart                            
Hayden IR                               
+1- 917-658-7878
hart@HaydenIR.com               

SOURCE Medbox, Inc.

RELATED LINKS
http://www.medboxinc.com

reade more... Résuméabuiyad